These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 30450625)
1. T11TS immunotherapy augments microglial and lymphocyte protective immune responses against Cryptococcus neoformans in the brain. Hazra I; Sk Md OF; Datta A; Mondal S; Moitra S; Singh MK; Chaudhuri S; Das PK; Basu AK; Dhar I; Basu N; Chaudhuri S Scand J Immunol; 2019 Feb; 89(2):e12733. PubMed ID: 30450625 [TBL] [Abstract][Full Text] [Related]
2. T11TS immunotherapy potentiates the repressed calcineurin-NFAT signalling pathway of T cells in Cryptococcus neoformans infected rats: a cue towards T-cell activation for antifungal immunity. Omar Faruk SM; Hazra I; Mondal S; Datta A; Moitra S; Das PK; Mishra R; Chaudhuri S J Appl Microbiol; 2020 Sep; 129(3):753-767. PubMed ID: 32145053 [TBL] [Abstract][Full Text] [Related]
3. MHC class II-positive perivascular microglial cells mediate resistance to Cryptococcus neoformans brain infection. Aguirre K; Miller S Glia; 2002 Aug; 39(2):184-8. PubMed ID: 12112369 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapy with T11TS / S-LFA-3 specifically induces apoptosis of brain tumor cells by augmenting intracranial immune status. Mukherjee J; Ghosh A; Sarkar P; Mazumdar M; Banerjee C; Chaudhuri S Anticancer Res; 2005; 25(4):2905-19. PubMed ID: 16080544 [TBL] [Abstract][Full Text] [Related]
5. Regulation of key molecules of immunological synapse by T11TS immunotherapy abrogates Cryptococcus neoformans infection in rats. Sk Md OF; Hazra I; Datta A; Mondal S; Moitra S; Chaudhuri S; Das PK; Basu AK; Mishra R; Chaudhuri S Mol Immunol; 2020 May; 122():207-221. PubMed ID: 32388483 [TBL] [Abstract][Full Text] [Related]
6. Role of CD4+ T cells in a protective immune response against Cryptococcus neoformans in the central nervous system. Uicker WC; McCracken JP; Buchanan KL Med Mycol; 2006 Feb; 44(1):1-11. PubMed ID: 16805087 [TBL] [Abstract][Full Text] [Related]
7. CD2-SLFA3/T11TS interaction facilitates immune activation and glioma regression by apoptosis. Sarkar S; Ghosh A; Mukherjee J; Chaudhuri S; Chaudhuri S Cancer Biol Ther; 2004 Nov; 3(11):1121-8. PubMed ID: 15467439 [TBL] [Abstract][Full Text] [Related]
9. Cryptococcus neoformans meningitis in the rat. Goldman DL; Casadevall A; Cho Y; Lee SC Lab Invest; 1996 Dec; 75(6):759-70. PubMed ID: 8973471 [TBL] [Abstract][Full Text] [Related]
10. Cytokine and chemokine expression in the central nervous system associated with protective cell-mediated immunity against Cryptococcus neoformans. Uicker WC; Doyle HA; McCracken JP; Langlois M; Buchanan KL Med Mycol; 2005 Feb; 43(1):27-38. PubMed ID: 15712606 [TBL] [Abstract][Full Text] [Related]
12. Protection from direct cerebral cryptococcus infection by interferon-gamma-dependent activation of microglial cells. Zhou Q; Gault RA; Kozel TR; Murphy WJ J Immunol; 2007 May; 178(9):5753-61. PubMed ID: 17442959 [TBL] [Abstract][Full Text] [Related]
13. The F-Box Protein Fbp1 Shapes the Immunogenic Potential of Masso-Silva J; Espinosa V; Liu TB; Wang Y; Xue C; Rivera A mBio; 2018 Jan; 9(1):. PubMed ID: 29317510 [No Abstract] [Full Text] [Related]
14. [Recognition mechanism of pathogen-associated molecular patterns and role of innate immune lymphocytes in fungal infection]. Kawakami K Rinsho Byori; 2009 Aug; 57(8):779-85. PubMed ID: 19764413 [TBL] [Abstract][Full Text] [Related]
16. Eosinophils elicit proliferation of naive and fungal-specific cells in vivo so enhancing a T helper type 1 cytokine profile in favour of a protective immune response against Cryptococcus neoformans infection. Garro AP; Chiapello LS; Baronetti JL; Masih DT Immunology; 2011 Oct; 134(2):198-213. PubMed ID: 21896014 [TBL] [Abstract][Full Text] [Related]
17. Role of capsule and interleukin-6 in long-term immune control of Cryptococcus neoformans infection by specifically activated human peripheral blood mononuclear cells. Siddiqui AA; Shattock RJ; Harrison TS Infect Immun; 2006 Sep; 74(9):5302-10. PubMed ID: 16926424 [TBL] [Abstract][Full Text] [Related]
18. Documentation of immune profile of microglia through cell surface marker study in glioma model primed by a novel cell surface glycopeptide T11TS/SLFA-3. Begum Z; Ghosh A; Sarkar S; Mukherjee J; Mazumdar M; Sarkar P; Chaudhuri S Glycoconj J; 2004; 20(9):515-23. PubMed ID: 15454689 [TBL] [Abstract][Full Text] [Related]
19. miR‑4792 regulates inflammatory responses in Yao G; Wang X; Wang Y; Hou Q; Gao R; Wang Y; Teng L; Lin W; Wang Z; Jin Y; Chen J Int J Mol Med; 2021 Nov; 48(5):. PubMed ID: 34498713 [TBL] [Abstract][Full Text] [Related]
20. T11 target structure exerts effector function by activating immune cells in CNS against glioma where cytokine modulation provide favorable microenvironment. Ghosh A; Bhattacharya M; Sarkar P; Acharya S; Chaudhuri S Indian J Exp Biol; 2010 Sep; 48(9):879-88. PubMed ID: 21506495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]